Clinical Trial

Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial

Study acronym: FOKAL-BT
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 11, 2017 (before its estimated December 2019 completion). Its status may not reflect the trial's current state.
Summary
This trial examines the feasibility and toxicity of focal brachytherapy in patients with low-risk prostate cancer.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2015-03-11; most recent amendment 2017-08-09.
Trial Details
NCT Number NCT02391051
Lead Sponsor University of Erlangen-Nürnberg Medical School
Conditions Prostate Cancer
Enrollment 50 participants
Start Date 2014-10
Primary Completion 2019-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2017-08-11